Showing 1021-1030 of 2853 results for "".
Imaging Outcome Measures in Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/imaging-outcome-measures-in-neuromuscular-diseases/35584/MRI is an important tool for assessing muscle and nerve changes in neuromuscular disease and is helpful to clinicians in monitoring therapeutic outcomes.Access to Newer AEDs and Specialists are Key to Seizure Control
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/access-to-newer-aeds-and-specialists-are-key-to-seizure-control/30541/A new report shows that some patients still lack access to care resources.Epilepsy Essentials: Neuromodulation Devices for Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-neuromodulation-devices-for-epilepsy/30165/Implantable devices are an emerging option for patients with medically refractory epilepsy who are not surgical candidates.Soft Skills for Challenging Times
https://practicalneurology.com/columns/practice-management/soft-skills-for-challenging-times/30399/An overview of skills practice administrators and other employees need in order to build a strong, successful team.Raising Urate With Inosine to Potentially Slow Progression of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focus/30688/Results of the Phase II SURE-PD study show inosine is safe and tolerable and raises urate levels, which have been inversely related to Parkinson's progression. Still, patients are cautioned against self-medicating before the next phase of this research effort is completed.Movement Disorders Moment: Rapid Eye Movement Sleep Behavior Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-rapid-eye-movement-sleep-behavior-disorder/30117/This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.Global Outcomes Data and Possible New Therapies in the Huntington's Pipeline
https://practicalneurology.com/diseases-diagnoses/movement-disorders/global-outcomes-data-and-possible-new-therapies-in-the-huntingtons-pipeline/30606/Researchers are focused on patient outcomes on a global scale and join clinicians in the vigil for new drug approvals.Special Report: 2023 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/imaging-testing/special-report-2023-neurology-drug-device-approvals/32081/A quick reference for the drugs and devices for neurologic conditions that received approval from the Food and Drug Administration last year.Immunotherapy for Management of Refractory and Super-Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/immunotherapy-for-management-of-refractory-and-super-refractory-status-epilepticus/39948/This review explores the role of neuroinflammation in refractory and super-refractory status epilepticus, as well as the role of therapeutic immunomodulation in their management.Medical Aid in Dying: An Overview for Neurologists
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/medical-aid-in-dying-an-overview-for-neurologists/35442/Life-limiting neurologic diseases can result in decreased quality of life despite excellent interdisciplinary care, and neurologists must be prepared for individuals with unrelieved suffering to make requests for hastened death.